65 results about "Midbrain" patented technology

The invention discloses a method and a related device for closed-loop optimization of a lower limb motor imagery experiment normal form through dynamic mind training, and relates to the field of rehabilitation medicines.The method comprises the steps that electroencephalogram signals of a testee when the testee executes a mind fusion lower limb motor imagery task are collected and preprocessed, and preprocessed electroencephalogram signal data are obtained; based on a dynamic feature extraction technology of a sliding window, calculating electrophysiological indexes in real time; performing weighted fusion on the motor imagery definition, the concentration degree and the correctness degree through predefined weights to generate a comprehensive state score; on the basis of the comprehensive state score, dynamically adjusting a normal feeling and task stimulation parameter applied to the testee; based on the collected electroencephalogram signals, extracting optimal perception motion rhythm and cross-frequency coupling characteristics; and inputting into the trained two-dimensional time convolution network decoding model to obtain the lower limb motor imagery intention of the testee. According to the method, the evoked rate and the stability of the electroencephalogram characteristics of the stroke patient in the lower limb motor imagery task can be improved.

The invention belongs to the technical field of brain function monitoring, and discloses a three-in-one non-invasive brain function monitoring system and method, a medium, equipment and application, and the monitoring method comprises the following steps: monitoring brain oxygen saturation of a critical patient; carrying out transcranial Doppler ultrasonic measurement on intracranial blood vessel blood flow velocity and ultrasonic measurement on the inner diameter of the optic nerve sheath; monitoring a quantitative electroencephalogram of the patient; various brain function monitoring series indexes and continuous changes of the indexes along with disease evolution are obtained, the pathogenic mechanism and pathogenesis of the indexes are found in time, and primary diseases and related complications of the primary diseases are treated. According to the invention, the brain oxygen saturation can avoid too low brain oxygen or low brain oxygen for a long time and too high brain oxygen due to oxygen utilization disorder; cerebral blood flow can be monitored through a transcranial Doppler (TCD) technology to find an optimal craniocerebral perfusion pressure (CPP), and a cerebral blood flow self-adjusting function is enabled to be in an optimal state; the electroencephalogram can avoid early warning of over-sedation or abnormal discharge and the like. Through organic combination of the three, noninvasive, real-time and dynamic monitoring of critical patients is realized.

The invention relates to the technical field of medical instruments, in particular to an ice stimulation training device for dysphagia rehabilitation, which comprises a box body with an upward opening, a cover plate arranged at the opening of the top of the box body, two partition plates arranged in an internal cavity at an interval up and down, and an auxiliary opening mechanism arranged in a training opening in the front side of the box body and used for opening the box body. An ice stimulation training head is arranged in the ice stimulation training device, the tail of the ice stimulation training head is connected with a control mechanism, and a pneumatic assembly is arranged on the left side of the top of the partition plate on the upper side and connected with the auxiliary opening mechanism through an air pressure rod assembly. The problems that in the prior art, an ice stimulation training device for rehabilitation of the stroke dysphagia generally can only achieve single ice stimulation treatment and lacks auxiliary taste stimulation and vibration stimulation for comprehensive treatment, so that the whole treatment process is long in time, more complex and free of cooperation, and the treatment cost is low are solved. Meanwhile, the compliance of the patient and the recognition degree of treatment are also reduced, and the patient cannot recover as soon as possible.

The present disclosure provides methods of producing midbrain dopaminergic neurons (mDAs) and precursors thereof, mDAs and precursors thereof produced thereby, as well as compositions comprising these cells, and their use for the prevention and / or treatment of neurological diseases. The present disclosure also provides methods of isolating mDA and precursors thereof from cell populations using novel surface markers.

The present invention relates to a method for identifying one or more caudal midbrain (cVM) progenitor cells by measuring the presence and / or amount of adenomatous colonic polyposis down-regulating 1 (APCDD1) expressed by one or more cells. The invention also provides a method for enriching cVM cells, application of the cells in disease treatment, application of APCDD1 as a biomarker and a kit.

The present disclosure provides methods of differentiating pluripotent stem cells, including inducible pluripotent stem cells, into lineage-specific midbrain floor progenitor cells, decisive dopaminergic neuron progenitor cells, definitive dopaminergic neuron progenitor cells, and / or dopaminergic neuron cells. Also provided are compositions use thereof, such as for the treatment of neurodegenerative diseases and conditions, including Parkinson's disease, as well as articles of manufacture and kits for use thereof.

The application provides a midbrain organoid and a preparation method and application thereof. The midbrain organoid is obtained in vitro by using pluripotent stem cells, can simulate the development and maturation rules of nerve cells in vivo, provides a solid foundation for later researches such as building a drug screening platform and modeling of diseases related to dopaminergic neurons, and opens up a new way for cell replacement therapy.

Described herein, inter alia, are compositions and methods of use for administering a population of regulatory T (TREG) cells and / or a population of midbrain dopamine (mDA) cells to the brain of a subject (e.g., treating Parkinson's disease and / or reducing immune responses due to acupuncture wounds during cell transplantation).

A method for assessing differentiation potential of cells in a culture broth in the differentiation of pluripotent stem cells into neural cells of the midbrain floor plate region, comprising: measuring a concentration of NT-3 in a culture supernatant in a culture broth obtained by culturing the pluripotent stem cells in a medium containing an inducer of differentiation into the neural cells of the midbrain floor plate region; comparing the measured concentration of NT-3 with a reference concentration; and when the concentration of NT-3 is equal to or more than the reference concentration, assessing the cells in the culture broth as capable of differentiating into the neural cells of the midbrain floor plate region, wherein the culture supernatant is a culture supernatant collected from the culture broth at any time from 48 hours to 240 hours after the start of culture of the pluripotent stem cells.

To provide methods for generating midbrain dopamine (mDA) neural progenitor cells useful for autologous cell therapy in Parkinson's disease, compositions comprising the cells, and methods of use thereof.SOLUTION: Provided is a method of producing a population of mesencephalic dopaminergic progenitor cells (mDAP), comprising the steps of providing a population of induced pluripotent stem cells (iPSC), preferably human iPSC, seeding said population of cells in discrete regions within a biological matrix hydrogel support at a density of about 5,000 to 20,000, preferably about 10,000 cells per region with a distance between said regions sufficient to maintain separation between said regions, and maintaining said cells under conditions sufficient for said iPSC to differentiate into mDAP.SELECTED DRAWING: None

The present disclosure provides methods of differentiating pluripotent stem cells, including induced pluripotent stem cells, into lineage-specific floor plate midbrain progenitor cells, determined dopaminergic neuronal progenitor cells, committed dopaminergic neuronal progenitor cells and / or dopaminergic neuronal cells. Also provided are compositions uses thereof, such as for treating neurodegenerative diseases and conditions, including Parkinson's disease, and articles of manufacture and kits for use thereof.

The present application relates to the technical field of medical image monitoring, in particular to an intraoperative cerebral oxygen saturation image dynamic monitoring and early warning system and method for elderly patients, comprising a bilateral cerebral oxygen acquisition module, a cerebral oxygen waveform image construction module, a cerebral oxygen image feature extraction module, a hierarchical early warning module and a multi-parameter linkage display module, through the bilateral cerebral oxygen saturation time series signals output by the bilateral near-infrared cerebral oxygen saturation sensors are synthesized into a double-channel cerebral oxygen waveform image aligned with the same time window start and end time and sharing the amplitude scale, three types of geometric morphological features of bilateral cerebral oxygen slope, bilateral cerebral oxygen asymmetry index and relative baseline drop amplitude are uniformly extracted in the image domain, three types of high-risk mode hierarchical triggering of unilateral cerebral oxygen threshold persistence, relative baseline drop and bilateral asymmetry are driven, and the invasive arterial pressure, cardiac output, anesthesia depth index waveform and hemodynamic event characteristic root cause pairing display are jointly presented.

Provided is a method for differentiating pluripotent stem cells in vitro to prepare a cell population mainly composed of midbrain floor plate dopaminergic progenitor cells, wherein the progenitor cells can efficiently and directionally differentiate into midbrain dopaminergic neuron precursors and midbrain dopaminergic neurons after being transplanted into a subject. Further provided is a cell population prepared by the method, a pharmaceutical composition containing the cell population, and a method for using the cell population or the pharmaceutical composition to treat or ameliorate a neurological disorder caused by a reduction in the number of midbrain dopaminergic neurons and / or impairment of function thereof.

This method allows for early and highly accurate assessment of the likelihood of developing central nervous system diseases (especially Parkinson's disease) in the future or currently being affected. [Solution] Based on the activity level of the pontine nuclei in the brain of a living organism, disease probability information is obtained, which indicates the likelihood of developing a central nervous system disease in the future.

The application discloses an induction method for directional differentiation of neural stem cells into dopaminergic neurons, comprising the following steps: S1, activation and adhesion of NSCs; S2, directional induction of midbrain precursor cells; S3, directional induction of dopaminergic neurons; and S4, synaptic function maturation induction. The induction method for directional differentiation of neural stem cells into dopaminergic neurons can significantly improve the directional efficiency and lineage specificity of the midbrain precursor cells: by adding salvianolic acid B and icariin, and in cooperation with SHH, FGF8 and other induction factors, the midbrain lineage-specific signal pathway can be efficiently activated, the positive rate of the midbrain precursor cell marker LMX1A is increased to more than 76%, which is far better than 49% of the existing system, and abnormal differentiation of non-midbrain lineages is effectively inhibited.

The invention discloses an NDUFS2 gene heterozygous editing pig as well as a construction method and application thereof, and relates to the field of animal gene engineering and disease model construction. The eighth exon of the NDUFS2 gene of the pig is deleted or mutated, and presents an NDUFS2 heterozygous genotype; in the newborn period, the number of neurons of the middle cerebral cortical layer and the number of dopaminergic neurons are obviously reduced, the number of neurons of the adult cortical layer is continuously reduced along with mitochondrial swelling and crest fracture, and after MPTP treatment, the number of neurons of the adult cortical layer is disordered in motion trail, and the body tremor index is increased. The pig model not only can be used for revealing the action mechanism of the NDUFS2 defect in neurodegenerative diseases (such as Parkinson's disease), but also can be used as an important tool for screening new drugs, evaluating treatment means and researching mitochondrial diseases.

The present disclosure provides automated methods of differentiating pluripotent stem cells, including induced pluripotent stem cells, into lineage-specific floor plate midbrain progenitor cells, such as dopaminergic neuronal progenitor cells, determined dopaminergic neuronal progenitor cells, committed dopaminergic neuronal progenitor cells and / or dopaminergic neuronal cells. Also provided are compositions uses thereof, such as for treating neurodegenerative diseases and conditions, including Parkinson's disease, and articles of manufacture and kits for use thereof.

The present invention relates to a method for directing differentiation of ventral midbrain NSCs into neurons comprising contacting a cell population comprising ventral midbrain NSCs with an inhibitor of MEK signaling and an inhibitor of NOTCH signaling, wherein the ventral midbrain NSCs co-express the markers FOXA2, LMX1A, EN1, OTX2, 5 and SOX2.

This invention relates to methods for increasing the regeneration of a skeletal muscle that comprise increasing the concentration of Mesencephalic Astrocyte-derived Neurotrophic Factor (MANF) in the skeletal muscle. The concentration of MANF may be increased by administering to the individual MANF, a nucleic acid encoding MANF, or a cell expressing MANF. This may be useful in the treatment of skeletal muscle damage or disease, for example in individuals with an age-related reduction in skeletal muscle regenerative capacity.

This disclosure relates to a method for producing induced midbrain dopaminergic progenitor cells (imDAPs) that can provide high imDAP cell differentiation efficiency. This disclosure also provides a substantially homogeneous imDAP cell population.

The present invention relates to a method for identifying one or more caudal ventral midbrain (cVM) progenitor cells by measuring the presence and / or amount of adenomatosis polyposis coli down-regulated 1 (APCDD1) expressed by one or more cells. The present invention also provides a method for enriching cVM cells, the use of said cells in the treatment of disease, the use of APCDD1 as a biomarker, and a kit.

The disclosure described herein provides, inter alia, a growth method for growing mDAPs and a combination of culture medium and coating matrix for use in the growth method, as well as a maturation method for maturing mDAPs and a culture medium for use in the maturation method. The present disclosure also provides a substantially homogeneous population of mDAPs, and a substantially homogeneous population of mDANs.

The application discloses an intraoperative brain protection device, which comprises an elastic support and a filter screen; the elastic support can be self-inflated on the inner wall of a blood vessel of an aortic arch and is attached to the inner wall of the blood vessel of the aortic arch, the elastic support is a ring-like structure surrounded by an elastic metal material, the distal end and the proximal end of the ring-like structure are upwardly curved to fix the intraoperative brain protection device in the aortic arch; the filter screen is located in the area surrounded by the elastic support, and the two ends of the filter screen are connected with the distal end and the proximal end of the ring-like structure respectively to block the thrombus generated in the operation from entering the head artery. The protection device adopts a left subclavian artery approach, compared with a traditional femoral artery protection device, the influence of other femoral artery access instruments on the femoral artery is reduced, the operation effect is guaranteed, and the application of the intraoperative brain protection device in the medical instrument technical field is facilitated.

The invention relates to the technical field of biology, in particular to a construction method of a novel lung cancer brain transfer model. The method comprises the following steps: carrying out induction culture on stem cells to obtain an embryoid organ, and carrying out differentiation culture on the embryoid organ to obtain a midbrain ventral organ; the method comprises the following steps: shearing and digesting small cell lung cancer (SCLC) tissue blocks to obtain SCLC cells, and carrying out suspension culture to obtain small cell lung cancer (SCLC) organs; and placing the midbrain ventral organ and the small cell lung cancer organ in the same culture container, and carrying out co-culture to obtain the novel lung cancer brain transfer model. Compared with a human-derived tumor tissue xenograft technology with a low success rate, the novel lung cancer brain transfer model provided by the embodiment of the invention has high fusion efficiency and batch stability, and interference of other heterologous animal components can be reduced. In addition, the organoid fusion model established by using the technology of the invention is easier to observe, deliver drugs and sample.

The present disclosure provides methods for generating midbrain dopamine neurons and their precursors, midbrain dopamine neurons and their precursors generated by such methods, compositions comprising such cells, and uses thereof for preventing, modeling, and / or treating neurological disorders. In certain embodiments, contacting the cells with at least one inhibitor of Wnt signaling begins at least about 5 days after initial contacting of the stem cells with at least one inhibitor of SMAD signaling.

The invention provides an efficient and repeatable in-vitro differentiation protocol, and human pluripotent stem cells are differentiated into functional midbrain dopaminergic neurons by accurately controlling sequential activation of SHH and FGF8 signal pathways. The protocol comprises five key differentiation stages: neural precursor induction, midbrain mode establishment, midbrain dopaminergic precursor amplification, terminal differentiation and maturation. Experiments prove that after the midbrain dopaminergic neuron obtained by the method is transplanted into a Parkinson's disease model animal body, the survival rate exceeds 80%, and the midbrain dopaminergic neuron can be effectively integrated into a host neural network and improve dyskinesia. According to the differentiation scheme, the purity (gt; gt) of mDA neurons is remarkably improved; 85%) and functional maturity, and a reliable cell source is provided for cell replacement treatment of Parkinson's disease.

The present application provides a method for producing, from pluripotent stem cells, neural progenitor cells of the midbrain floor plate region or dopaminergic neural progenitor cells, the method comprising (1) inducing differentiation of pluripotent stem cells into neural progenitor cells of the midbrain floor plate region, and optionally (2) inducing differentiation of the neural progenitor cells of the midbrain floor plate region, which are obtained by the differentiation induced in (1), into dopaminergic neural progenitor cells, wherein all or part of the differentiation induced in (1) includes culturing the cells in a medium containing an agonist for LPA receptor.

The disclosure described herein provides, inter alia, a growth method for growing mDAPs and a combination of culture medium and coating matrix for use in the growth method, as well as a maturation method for maturing mDAPs and a culture medium for use in the maturation method. The present disclosure also provides a substantially homogeneous population of mDAPs, and a substantially homogeneous population of mDANs.

The invention relates to the technical field of scalpels, in particular to an integrated brain glioma scalpel which comprises a scalpel rod, a driving mechanism, a reciprocating cutting mechanism, a transmission mechanism and a suction mechanism, and the scalpel rod is provided with a first cavity formed in the axial direction; the driving mechanism is arranged at one end of the cutter bar; the reciprocating cutting mechanism is arranged at the other end of the cutter bar; the transmission mechanism is connected with the driving mechanism and the reciprocating cutting mechanism through the first cavity. The suction mechanism is arranged around the reciprocating cutting mechanism and used for sucking the body fluid and discharging the body fluid through the first cavity. The problem that in the prior art, a brain glioma excision scalpel is prone to damaging normal brain tissue due to the requirement for the activity space is effectively solved.